By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN
The Innovator’s Pitch Challenge (IPC) returns to RESI Boston this June with a robust lineup of 14 pitch sessions featuring early-stage companies from across the life science spectrum. Finalists span core sectors including Medical Devices, R&D, Therapeutics, Diagnostics, and Digital Health. Several sessions will highlight technologies with a specific focus—such as surgical applications, oncology, gene therapy, and advanced delivery systems—providing a deeper look at high-impact areas of healthcare innovation.
These sessions offer RESI attendees the opportunity to explore a wide range of breakthrough solutions and meet the entrepreneurs behind them. Each company will present to a panel of active investors and strategic partners, engaging in live Q&A and receiving valuable feedback. Beyond the pitch stage, IPC finalists will also be featured in the RESI exhibition hall, where they will host tables to continue conversations and meet one-on-one with potential partners and investors.
IPC voting will take place online throughout the conference, with attendees selecting their top picks. The three companies with the highest number of votes will be recognized at the conclusion of the event and featured in Life Science Nation’s Next Phase newsletter. In addition to this recognition, winners will receive complimentary registration to future RESI conferences.
More than just a pitch event, the IPC is designed to help fundraising companies gain visibility, validate their approach, and connect with a global network of partners in the early-stage life science ecosystem.
See the full list of pitching companies:
Next Phase Newsletter 
Leave a comment